NXTMH.HE Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 16:17):

Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally...

Stats
Dzisiejszy wolumen	13 275.00
Średni wolumen	10 654.00
Kapitalizacja rynkowa	18.00M
EPS	€0 ( 2024-02-27 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-13.30
ATR14	€0.0160 (0.60%)

Wolumen Korelacja

Długi: 0.17 (neutral)

Krótki: -0.83 (strong negative)

Signal:(47.376) Neutral

Nexstim Plc Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nexstim Plc Korelacja - Waluta/Towar

-0.61
( weak negative )

-0.68
( moderate negative )

0.00
( neutral )

-0.59
( weak negative )

0.61
( weak )

0.60
( weak )

Nexstim Plc Finanse

Annual	2023
Przychody:	€7.25M
Zysk brutto:	€1.85M (25.57 %)
EPS:	€-0.200

FY	2023
Przychody:	€7.25M
Zysk brutto:	€1.85M (25.57 %)
EPS:	€-0.200

FY	2022
Przychody:	€9.53M
Zysk brutto:	€9.52M (99.95 %)
EPS:	€0.200

FY	2021
Przychody:	€6.40M
Zysk brutto:	€6.22M (97.23 %)
EPS:	€-0.243

Financial Reports:

No articles found.

Nexstim Plc

Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.